RecallRadar

FDA Drug recall D-0326-2021

Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav…

On 2021-04-14 the FDA classified a Class I recall of Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav… by Alembic Pharmaceuticals, citing labeling: Label-mixup.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0326-2021
ClassificationClass I
Statusterminated
Initiated2021-03-17
Published2021-04-14
Last updated2026-09-13 11:52 UTC
CompanyAlembic Pharmaceuticals
DistributionUS

Product

Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 38935, Gujarat, India Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807, NDC 62332-087-30

Reason

Labeling: Label-mixup

Identifiers

ndc62332-087-30
ndc62332-087-91
ndc62332-088-30
ndc62332-088-91
ndc62332-089-30
ndc62332-089-91
ndc1905005661
code_infoLot #: 1905005661, Exp March 2022

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0326-2021%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.